Complement C1q-target proteins recognition is inhibited by electric moment effectors.

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• The classical complement pathway is vital for innate immunity but can cause tissue damage if overactivated.
• Understanding complement activation and inhibition is crucial for biomedical applications.
• C1q binding to targets initiates the classical pathway, a process influenced by calcium and electric moments.

Purpose of the Study:

• To elucidate the mechanism by which low molecular weight disulphate compounds inhibit C1q.
• To investigate how these inhibitors interact with the globular (gC1q) domain of C1q.

Main Methods:

• Experimental assays to test inhibitor efficacy.
• Computational docking to model C1q-inhibitor interactions.
• Theoretical modeling to understand the biophysical mechanisms involved.

Main Results:

• Betulin disulphate (B2S) and F2S inhibit C1q interaction with IgG1, CRP, and PTX3.
• Inhibitors alter electric/dipole moment vectors, reducing electrostatic steering and target recognition.
• Inhibitors likely block the conformational change of C1q required for complement activation.

Conclusions:

• Disulphate compounds effectively inhibit classical complement pathway initiation by targeting C1q.
• Inhibition occurs by disrupting C1q's electric moment, impairing target binding and conformational changes.
• These findings suggest a novel class of 'electric moment inhibitors' for therapeutic development.